Physician profile
Stephanie Fleming
NPI 1396154225
$1,038.89
in general payments reported to CMS, 2019-2025
9 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $300 · 2024: $469 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $270.83 | 2024-2025 | Monoferric |
| Amgen INC. | $146.27 | 2023-2024 | Blincyto |
| Chiesi USA, INC. | $124.99 | 2024 | Ferriprox |
| Averitas Pharma INC. | $124.86 | 2023 | Qutenza |
| Glaxosmithkline, LLC. | $120.38 | 2025 | Ojjaara |
| Abbvie INC. | $95.49 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $71.28 | 2023 | Reblozyl |
| Janssen Pharmaceuticals, INC | $63.54 | 2023 | Xarelto |
| Gilead Sciences, INC. | $21.25 | 2023 | Trodelvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.